Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.19 by 42.11 percent. This is a 145.45 percent increase over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $214.300 million which beat the analyst consensus estimate of $206.091 million by 3.98 percent. This is a 55.53 percent increase over sales of $137.785 million the same period last year.